Search - tctmd.com

Displaying 481 - 500 of 533

Sort: Relevancy | Date

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

El Tratamiento con Células Madre Cardíacas es Seguro y Podría Regenerar el Tejido Cardíaco

Caitlin E. Cox

March 06, 2012

News Daily News

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Caitlin E. Cox

March 06, 2012

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

News Daily News

Las Sociedades Recomiendan los Requisitos para el Programa TAVR

L.A. McKeown

March 06, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Daily News

Fewer Vascular Complications as TAVR Evolves

Caitlin E. Cox

January 10, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

News Daily News

Transcatheter Pulmonary Valve Prone to Stent Fracture

Jason Kahn

December 07, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

November 08, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

News Conference News

Polymer-free DES Shown Effective in Multiple Trials

November 08, 2011

Advertisement

Experts Give Their Picks for Most Important Developments of 2011

El Tratamiento con Células Madre Cardíacas es Seguro y Podría Regenerar el Tejido Cardíaco

Cardiac Stem Cell Therapy Safe, May Regenerate Heart Tissue

Societies Recommend TAVR Program Requirements

Las Sociedades Recomiendan los Requisitos para el Programa TAVR

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Expedited Cell Therapy After STEMI Shows Promise

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Fewer Vascular Complications as TAVR Evolves

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Transcatheter Pulmonary Valve Prone to Stent Fracture

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

SPIRIT PRIME: EES Efficacy ‘Similar and Consistent’ with Xience V Technology

Safety, Efficacy Reported with FIREHAWK SES

PROTECT II: Positive Outcomes Observed with Impella Device

Polymer-free DES Shown Effective in Multiple Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content